48 results
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
4.19 shall not apply in respect of an Exempt Issuance.
4.20 Research Independence. The Company acknowledges that each Underwriter’s research analysts
8-K
EX-1.1
mka8og2rjdjl
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
424B4
0icdi1v713yx
21 May 20
Prospectus supplement with pricing info
6:04am